Shares of Moderna grew by 5.25% to $93.56 at 13:05 EST on Thursday. The Nasdaq Stock Market is rising 0.41% to $11850, on what seems, as yet, a somewhat positive trend trading session on The Nasdaq Stock Market.
Moderna’s last close was $88.89, below its 52-week high of $103.2.
Moderna’s sales growth is 1216.8% for the ongoing quarter and 2299% for the next. The company’s growth estimates for the current quarter and the next is a negative 67.6% and a positive 142.9%, respectively.
Year-on-year quarterly revenue growth grew by 826.4%, now sitting on 246.7M for the twelve trailing months.
Moderna’s stock is valued at $93.56 at 13:05 EST, below its 52-week high of $103.2 and way above its 52-week low of $17.68.
Moderna’s value is way above its 50 day moving average of $74.76 and way higher than its 200 day moving average of $68.76.
According to today’s article on Bloomberg Quint, “Moderna Vaccine Production Is Gearing Up, Partner Lonza Says.”